By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Generex Biotechnology Corporation 

33 Harbour Square
Suite 202
Toronto  Ontario  M5J 2G2  Canada
Phone: 416-364-2551 Fax: 416-364-9363


SEARCH JOBS


Industry
Biotechnology

Segment
Drug Delivery





Company News
Generex Biotechnology Corporation (GNBT) Announces Interview Of Dr. Eric Von Hofe, President Of Antigen Express, Inc. (GNBT), Following Recent Keynote Presentation 6/17/2014 10:27:43 AM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial 6/13/2014 12:45:03 PM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announce Interview Of MD Anderson Cancer Center's Dr. Elizabeth Mittendorf, Principal Investigator On Company's AE37 Phase IIb Breast Cancer Efficacy Trial 6/12/2014 8:21:57 AM
Generex Biotechnology Corporation (GNBT) / Antigen Express, Inc. (GNBT) To Participate In 2014 Biotechnology Industry Organization (BIO) International Convention 6/10/2014 7:49:21 AM
Generex Biotechnology Corporation (GNBT) Announces Presentation Of Primary Efficacy Data & Immunological Response From The Phase II Study Of AE37 Cancer Vaccine At American Society of Clinical Oncology 5/20/2014 8:32:15 AM
Generex Biotechnology Corporation (GNBT) Announces Antigen Express AE37 Breast Cancer Vaccine Abstract Presentations At American Society of Clinical Oncology 2014 Annual Meeting 4/23/2014 7:48:40 AM
Generex Biotechnology Corporation (GNBT) Announces $2,075,000 Capital Investment 3/27/2014 9:30:29 AM
Generex Biotechnology Corporation (GNBT)/Antigen Express, Inc. (GNBT) Announces Participation On Panel At Upcoming Cancer Immunotherapeutics Symposium 3/26/2014 7:44:03 AM
Generex Biotechnology Corporation (GNBT) Subsidiary Antigen Express Receives Patents For Vaccines Targeting HPV Induced Cancers And Influenza 3/5/2014 10:42:12 AM
Generex Biotechnology Corporation (GNBT) Announces Publication Of Biomarker Studies Related To The Antigen Express Novel Immunotherapeutic AE37 In Prostate Cancer Patients 2/27/2014 10:22:06 AM
12345678910...
//-->